Table 2.
Associations between expression of E-cadherin, vimentin, and clinicopathologic characteristics.
Variable | Category | E-cadherin | P | Vimentin | P | ||
---|---|---|---|---|---|---|---|
Positive | Negative | Positive | Negative | ||||
Age | 64.24, mean | 63.19, mean | 0.639 | 64.62, mean | 62.69, mean | 0.501 | |
| |||||||
Gender | Female | 15 | 20 | 0.449 | 18 | 17 | 0.715 |
Male | 34 | 33 | 37 | 30 | |||
| |||||||
Drinking history | Yes | 9 | 11 | 0.762 | 7 | 13 | 0.058 |
No | 40 | 42 | 48 | 34 | |||
| |||||||
Smoking history | Yes | 16 | 14 | 0.490 | 16 | 14 | 0.939 |
No | 33 | 39 | 39 | 33 | |||
| |||||||
Family history | Yes | 4 | 3 | 0.708 | 3 | 4 | 0.543 |
No | 45 | 50 | 52 | 43 | |||
| |||||||
BMI | 25.04, mean | 24.83, mean | 0.876 | 24.68, mean | 25.2, mean | 0.888 | |
| |||||||
CEA | 8.24, mean | 14.23, mean | 0.007∗ | 13.76, mean | 8.75, mean | 0.105 | |
| |||||||
CA19-9 | 23.46, mean | 36.58, mean | 0.048∗ | 42.27, mean | 17.31, mean | 0.009∗ | |
| |||||||
Sulfonylurea | Yes | 27 | 20 | 0.079 | 24 | 23 | 0.592 |
No | 22 | 33 | 31 | 24 | |||
| |||||||
Insulin | Yes | 13 | 21 | 0.161 | 24 | 11 | 0.032∗ |
No | 36 | 32 | 31 | 36 | |||
| |||||||
Site | Right | 9 | 10 | 0.934 | 9 | 10 | 0.770 |
Transverse | 2 | 3 | 2 | 3 | |||
Left | 2 | 4 | 4 | 2 | |||
Sigmoid | 10 | 9 | 9 | 10 | |||
Rectum | 26 | 27 | 31 | 22 | |||
| |||||||
Histologic grade | I-II | 40 | 45 | 0.658 | 43 | 42 | 0.131 |
III | 9 | 8 | 12 | 5 | |||
| |||||||
T | T1–3 | 35 | 17 | <0.001∗ | 23 | 29 | 0.045∗ |
T4 | 14 | 36 | 32 | 18 | |||
| |||||||
N | N0 | 35 | 25 | 0.013∗ | 24 | 36 | 0.001∗ |
N1-2 | 14 | 28 | 31 | 11 |
∗ P < 0.05.